DTF funding - Omega One - Glutathione Transferase Omega One (GSTO1) inhibitors as anti inflammatory therapeutics

  • Board, Philip (PI)
  • Baell, Jonathan B (CoI)

    Project: Research

    Project Details


    BEC administered - This DTF grant is to provide seed funding for the company Omega-One Therapeutics, established from the CUREator biotechnology incubator grant (see linked record 41258) - The project involves the validation of novel, patentable, anti-inflammatory compounds developed jointly by ANU and Monash University. The overall commercialisation strategy for this program is to complete drug-lead optimisation under the CUREator grant, secure Series A investment for pre-clinical studies, then package an FDA approved Investigational New Drug (IND) ready clinical candidate at a substantial valuation increase for further investment or acquisition. CUREator/DTF funding will position the project to attract the Seed investor. The results of the CUREator / DTF project will significantly improve our position with these groups and potentially others.
    Effective start/end date1/08/221/07/23


    • ANU Connect Ventures Pty Ltd (Discontinued): A$50,000.00


    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.